Cannabis Regulation: FDA, State, and Stakeholder Perspectives
March 26, 2025 | 12:30PM–4:30PM | In-Person & Virtual Event
Overview
Amid proposed rulemaking to reschedule cannabis and the changing landscape in the new Administration, regulation of cannabis and cannabis-derived products at the state and federal level poses challenges for stakeholders. This program provides the latest updates and developments from FDA and state regulators followed by practical recommendations from industry, advocates, entrepreneurs, and other stakeholders.
Register
*Members of the Cannabis Regulators Association (CANNRA) are eligible for a limited number of complimentary registrations for the conference (in-person or virtual), available on a first-come, first-served basis. Please complete the form here.
Sponsors
Sponsorship opportunities are available. Please let us know if you would like more information.
Planning Committee
William Garvin, Buchanan Ingersoll & Rooney PC
Larry K. Houck, Hyman, Phelps & McNamara, PC
Andrew J. Kline, Perkins Coie LLP
Agustin E. Rodriguez, Troutman Pepper Hamilton Sanders LLP
Daniel Charles Rubenstein, Steptoe LLP
Frederick A. Stearns, Keller and Heckman LLP
